A Peri-intubation Oral Intervention to Reduce Oral Flora and VAP
2 other identifiers
interventional
156
1 country
1
Brief Summary
The purpose of this study is determine if a single, early dose of chlorhexidine applied within 12 hours after endotracheal tube insertion will reduce the bacteria in the oral cavity and the incidence of pneumonia in trauma victims.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Aug 2005
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2005
CompletedFirst Submitted
Initial submission to the registry
November 1, 2005
CompletedFirst Posted
Study publicly available on registry
November 3, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2008
CompletedNovember 11, 2015
November 1, 2015
3 years
November 1, 2005
November 9, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Oral microbial flora -- measured by semi-quantitative oral culture
At 24, 48 and 72 hours after intubation
Secondary Outcomes (1)
Incidence of ventilator associated pneumonia, measured by the clinical pulmonary infection score (CPIS) and obtained on study admission, 48 and 72 hours after intubation
At 48 and 72 hours after intubation.
Interventions
Chlorhexidine, 5 ml swab to the oral cavity within 12 hours of endotracheal tube intubation
Eligibility Criteria
You may qualify if:
- trauma victim
- endotracheal intubation within the past 12 hours
- mechanical ventilation
You may not qualify if:
- diagnosis of pneumonia at the time of intubation
- previous endotracheal tube placement in the last 48 hours
- burn injuries
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Virginia Commonwealth Universitylead
- United States Department of Defensecollaborator
- Uniformed Services University of the Health Sciencescollaborator
- TriService Nursing Research Programcollaborator
Study Sites (1)
Virginia Commonwealth University School of Nursing
Richmond, Virginia, 23298, United States
Related Publications (1)
Grap MJ, Munro CL, Elswick RK Jr, Sessler CN, Ward KR. Duration of action of a single, early oral application of chlorhexidine on oral microbial flora in mechanically ventilated patients: a pilot study. Heart Lung. 2004 Mar-Apr;33(2):83-91. doi: 10.1016/j.hrtlng.2003.12.004.
PMID: 15024373BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary Jo E Grap, PhD
Virginia Commonwealth University School of Nursing
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 2005
First Posted
November 3, 2005
Study Start
August 1, 2005
Primary Completion
August 1, 2008
Study Completion
August 1, 2008
Last Updated
November 11, 2015
Record last verified: 2015-11